🇺🇸 FDA
Patent

US 11814410

Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof

granted A61PA61P35/00

Quick answer

US patent 11814410 (Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P35/00